Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,820 | -37,630 | -22,936 | -13,846 | -175,239 |
| Depreciation Amortization | 19,378 | 24,804 | 10,146 | 5,479 | 142,466 |
| Income taxes - deferred | -3,736 | -3,372 | -1,014 | -557 | 11,466 |
| Accounts receivable | -16,303 | -2,978 | -1,393 | 1,484 | 2,388 |
| Accounts payable and accrued liabilities | 3,066 | 3,874 | 1,596 | -245 | -6,896 |
| Other Working Capital | -7,239 | -23,427 | 2,325 | 4,908 | 2,841 |
| Other Operating Activity | 69,714 | 34,771 | 22,827 | 10,043 | 49,977 |
| Operating Cash Flow | $21,060 | $-3,958 | $11,551 | $7,266 | $27,003 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -122,620 | -96,201 | -98,756 | -100,291 | 16,644 |
| PPE Investments | -40,002 | -36,224 | -16,725 | -3,798 | -21,432 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -399 |
| Sale Of Investment | 104,270 | 101,528 | 75,599 | 56,903 | 44,085 |
| Investing Cash Flow | $-58,352 | $-30,897 | $-39,882 | $-47,186 | $38,898 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,774 | -1,638 | -1,502 | -900 | -4,996 |
| Common Stock Issued | 51 | N/A | N/A | N/A | 3 |
| Common Stock Repurchased | -3,124 | -2,882 | -2,451 | -1,907 | -27,792 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -15,000 |
| Financing Cash Flow | $-4,847 | $-4,520 | $-3,953 | $-2,807 | $-47,785 |
| Exchange Rate Effect | -55 | 79 | -78 | -69 | -149 |
| Beginning Cash Position | 97,473 | 97,473 | 97,473 | 97,473 | 79,506 |
| End Cash Position | 55,279 | 58,177 | 65,111 | 54,677 | 97,473 |
| Net Cash Flow | $-42,194 | $-39,296 | $-32,362 | $-42,796 | $17,967 |
| Free Cash Flow | |||||
| Operating Cash Flow | 21,060 | -3,958 | 11,551 | 7,266 | 27,003 |
| Capital Expenditure | -40,315 | -36,537 | -17,000 | -4,056 | -22,207 |
| Free Cash Flow | -19,255 | -40,495 | -5,449 | 3,210 | 4,796 |